Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov 5;11(11):1640.
doi: 10.3390/biom11111640.

Advances in Parkinson's Disease Drugs

Affiliations
Editorial

Advances in Parkinson's Disease Drugs

Antonio Di Stefano et al. Biomolecules. .

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative age-related disorder worldwide after Alzheimer's disease [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

References

    1. Bologna M., Truong D., Jankovic J. The etiopathogenetic and pathophysiological spectrum of parkinsonism. J. Neurol. Sci. 2021:120012. doi: 10.1016/j.jns.2021.120012. - DOI - PubMed
    1. Laserra S., Basit A., Sozio P., Marinelli L., Fornasari E., Cacciatore I., Ciulla M., Türkez H., Geyikoglu F., Di Stefano A. Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization. Int. J. Pharm. 2015;485:183–191. doi: 10.1016/j.ijpharm.2015.03.001. - DOI - PubMed
    1. Armstrong M.J., Okun M.S. Diagnosis and treatment of Parkinson disease: A review. JAMA. 2020;323:548–560. doi: 10.1001/jama.2019.22360. - DOI - PubMed
    1. Miller K.M., Mercado N.M., Sortwell C.E. Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor. NPJ Park. Dis. 2021;7:35. doi: 10.1038/s41531-021-00179-6. - DOI - PMC - PubMed
    1. Aarsland D., Batzu L., Halliday G.M., Geurtsen G.J., Ballard C., Chaudhuri K.R., Weintraub D. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Primers. 2021;7:47. doi: 10.1038/s41572-021-00280-3. - DOI - PubMed

MeSH terms

Substances